Guiping Li
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
-
- Traditional Chinese Medicine Analysis
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 2
- Co-authors
- Weizu Li (1 shared paper)Weiping Li (1 shared paper)Xiong Li (1 shared paper)Rong Ma (1 shared paper)Li Sun (1 shared paper)Quanshi Wang (3 shared papers)Kai Huang (3 shared papers)Yue Sun (5 shared papers)
- Journals
- Nuclear Medicine and Biology (2 papers)Biomedicine & Pharmacotherapy (2 papers)World Journal of Gastroenterology (2 papers)Journal of Investigative Medicine (1 paper)Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guiping Li
51 papers receiving 487 citations
Peers
Comparison fields: 5 of 81
- Nephrology 51
- Complementary and alternative medicine 38
- Radiology, Nuclear Medicine and Imaging 58
- Endocrinology, Diabetes and Metabolism 41
- Hepatology 16
Countries citing papers authored by Guiping Li
This map shows the geographic impact of Guiping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiping Li more than expected).
Fields of papers citing papers by Guiping Li
This network shows the impact of papers produced by Guiping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiping Li. The network helps show where Guiping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 64 | |
| 2 | 2018 | 46 | |
| 3 | 2017 | 40 | |
| 4 | 2012 | 30 | |
| 5 | 2017 | 28 | |
| 6 | 2005 | 22 | |
| 7 | 2021 | 18 | |
| 8 | 2018 | 18 | |
| 9 | 2019 | 17 | |
| 10 | 2020 | 17 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2006 | 11 | |
| 15 | Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer. | 2014 | 10 |
| 16 | 2022 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2019 | 8 |
About Guiping Li
Guiping Li is a scholar working on Oncology, Epidemiology, Endocrinology, Diabetes and Metabolism, Pharmacology and Pathology and Forensic Medicine, having authored 56 papers that have together received 496 indexed citations. Recurring topics across this work include Coffee research and impacts (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Diabetes Treatment and Management (3 papers), Lung Cancer Treatments and Mutations (3 papers), Tea Polyphenols and Effects (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Acupuncture Treatment Research Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Nephrology (51 citations), Complementary and alternative medicine (38 citations), Radiology, Nuclear Medicine and Imaging (58 citations), Endocrinology, Diabetes and Metabolism (41 citations) and Hepatology (16 citations). Guiping Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weizu Li, Weiping Li, Xiong Li, Rong Ma, Li Sun, Quanshi Wang, Kai Huang, Yue Sun, Qian Zhang and Yaoming Xue. Their work appears in journals such as Nuclear Medicine and Biology, Biomedicine & Pharmacotherapy, World Journal of Gastroenterology, Journal of Investigative Medicine and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.